Fig. 2

The molecular function of lnc-CHAF1B-2 was explored in HGC-27 and AGS cells. (A) Examination of lnc-CHAF1B-2 expression in five human gastric cancer cell lines via RT‒qPCR. The abundance of lnc-CHAF1B-2 was relatively high in AGS cells and relatively low in HGC-27 cells. (B) lnc-CHAF1B-2 inhibitory gastric cancer cell lines were established in AGS cells using siRNA1. (C) The lnc-CHAF1B-2-overexpressing gastric cancer cell line was established in HGC-27 cells using lentiviral transduction. NC: blank control group, siRNA1:small interfering RNA1, siRNA2:small interfering RNA2, siRNA3:small interfering RNA3, Vector: empty vector, OE: lnc-CHAF1B-2 overexpression.*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.